Vigabatrin and tiagabine are pharmacologically different drugs. A pre-clinical study

This publication has 43 references indexed in Scilit:

• Basic Mechanisms of Epilepsy: Targets for Therapeutic Intervention
  Epilepsia, 1997
• Update on the Mechanism of Action of Antiepileptic Drugs
  Epilepsia, 1996
• New Antiepileptic Drugs
  New England Journal of Medicine, 1996
• Antiepileptic drugs, clinical trials, and the marketplace
  The Lancet, 1996
• Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1
  European Journal of Pharmacology: Molecular Pharmacology, 1994
• Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?
  Epilepsy Research, 1994
• New Antiepileptic Drugs: From Serendipity to Rational Discovery
  Epilepsia, 1992
• Vigabatrin
  Drugs, 1991
• GABA‐TRANSAMINASES OF HUMAN BRAIN AND PERIPHERAL TISSUES—KINETIC AND MOLECULAR PROPERTIES
  Journal of Neurochemistry, 1978
• 4‐Amino‐hex‐5‐enoic Acid, a Selective Catalytic Inhibitor of 4‐Aminobutyric‐Acid Aminotransferase in Mammalian Brain
  European Journal of Biochemistry, 1977